Intrinsic immunity: a front-line defense against viral attack (Q34360874)

1 August 2017

1 reference

title

Intrinsic immunity: a front-line defense against viral attack (English)

1 reference

1 August 2017

1

Paul D Bieniasz

1 reference

PubMed ID

15496950

1 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

1 August 2017

1 reference

1 August 2017

5

1 reference

1 August 2017

1109-1115

1 reference

1 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/ni1125

1 August 2017

0 references

cites work

Receptor interference groups of 20 retroviruses plating on human cells

1 reference

7 January 2021

Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties

1 reference

7 January 2021

Late viral interference induced by transdominant Gag of an endogenous retrovirus

1 reference

7 January 2021

Susceptibility to two strains of Friend leukemia virus in mice

1 reference

7 January 2021

Akvr-1, a dominant murine leukemia virus restriction gene, is polymorphic in leukemia-prone wild mice

1 reference

7 January 2021

Resistance of fibroblasts and hematopoietic cells to ecotropic murine leukemia virus infection; an Akvr-1R gene effect

1 reference

7 January 2021

A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses

1 reference

7 January 2021

Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice

1 reference

7 January 2021

Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1 b strains of mice

1 reference

7 January 2021

Analysis of wild-derived mice for Fv-1 and Fv-2 murine leukemia virus restriction loci: a novel wild mouse Fv-1 allele responsible for lack of host range restriction

1 reference

7 January 2021

Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance

1 reference

7 January 2021

Replication kinetics of N- and B-tropic murine leukemia viruses on permissive and nonpermissive cells in vitro

1 reference

7 January 2021

Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle

1 reference

7 January 2021

A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures

1 reference

7 January 2021

Characterization of Fv-1 host range strains of murine retroviruses by titration and p30 protein characteristics

1 reference

7 January 2021

Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line

1 reference

7 January 2021

Positional cloning of the mouse retrovirus restriction gene Fv1.

1 reference

7 January 2021

Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins

1 reference

7 January 2021

Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly

1 reference

7 January 2021

Use of a transient assay for studying the genetic determinants of Fv1 restriction

1 reference

7 January 2021

Identification of the regions of Fv1 necessary for murine leukemia virus restriction.

1 reference

7 January 2021

A conserved mechanism of retrovirus restriction in mammals

1 reference

7 January 2021

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

1 reference

7 January 2021

Restriction of lentivirus in monkeys

1 reference

7 January 2021

A dominant block to HIV-1 replication at reverse transcription in simian cells

1 reference

7 January 2021

Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells

1 reference

7 January 2021

Restriction of multiple divergent retroviruses by Lv1 and Ref1

1 reference

7 January 2021

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

1 reference

7 January 2021

The tripartite motif family identifies cell compartments

1 reference

7 January 2021

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha

1 reference

7 January 2021

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities

1 reference

7 January 2021

TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells

1 reference

7 January 2021

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

1 reference

7 January 2021

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors

1 reference

7 January 2021

Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly

1 reference

7 January 2021

Assembly and analysis of conical models for the HIV-1 core.

1 reference

7 January 2021

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

1 reference

7 January 2021

Intracellular localisation of Fv1

1 reference

7 January 2021

BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta

1 reference

7 January 2021

Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

1 reference

7 January 2021

Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles

1 reference

7 January 2021

A new ticket for entry into budding vesicles-ubiquitin

1 reference

7 January 2021

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

7 January 2021

Evidence for a newly discovered cellular anti-HIV-1 phenotype

1 reference

7 January 2021

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

7 January 2021

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

7 January 2021

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

7 January 2021

DNA deamination mediates innate immunity to retroviral infection

1 reference

7 January 2021

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

7 January 2021

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

1 reference

7 January 2021

Differential Association of Uracil DNA Glycosylase with SIVSMVpr and Vpx Proteins

1 reference

7 January 2021

Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme

1 reference

7 January 2021

The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate

1 reference

7 January 2021

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

1 reference

7 January 2021

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

1 reference

7 January 2021

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

1 reference

7 January 2021

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

1 reference

7 January 2021

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

1 reference

7 January 2021

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

7 January 2021

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

7 January 2021

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

7 January 2021

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

7 January 2021

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

7 January 2021

Inhibition of hepatitis B virus replication by APOBEC3G.

1 reference

7 January 2021

Natural and iatrogenic variation in hepatitis B virus

1 reference

7 January 2021

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes

1 reference

7 January 2021

APOBEC-mediated editing of viral RNA.

1 reference

7 January 2021

Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein

1 reference

7 January 2021

Expression of the zinc-finger antiviral protein inhibits alphavirus replication

1 reference

7 January 2021

Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production

1 reference

7 January 2021

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

1 reference

7 January 2021

Cell type-dependence for Vpu function

1 reference

7 January 2021

Function of human immunodeficiency virus type 1 Vpu protein in various cell types.

1 reference

7 January 2021

Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication

1 reference

7 January 2021

Trim5alpha protein restricts both HIV-1 and murine leukemia virus

1 reference

7 January 2021

As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity

1 reference

7 January 2021

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

1 reference

7 January 2021

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

1 reference

7 January 2021

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action

1 reference

7 January 2021

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

1 reference

7 January 2021

Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.

1 reference

7 January 2021

The interaction between HIV-1 Gag and APOBEC3G.

1 reference

7 January 2021

APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein

1 reference

7 January 2021

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

1 reference

7 January 2021

APOBEC3G targets specific virus species.

1 reference

7 January 2021

Innate immune recognition

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI1125

1 reference

PubMed ID

15496950

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

15496950